(Circulation. 2004;109:2716-2719.)
© 2004 American Heart Association, Inc.
Brief Rapid Communications |
From the Erasmus Medical Center, Thoraxcenter, Rotterdam (J.A.S., E.R., F.M., E.P.M., F.S., C.L.K., P.J.F., A.F.W.S., P.W.S.); the Interuniversity Cardiology Institute of the Netherlands, Utrecht (J.A.S., C.L.K., A.F.W.S.); and Cardialysis BV, Rotterdam (C.D.), the Netherlands.
Correspondence to Johannes A. Schaar, MD, Erasmus Medical Center, Thoraxcenter Rotterdam, Kamer Ee 23.32, PO Box 1738, 3000 DR Rotterdam, The Netherlands. E-mail j.schaar{at}erasmusmc.nl
Received January 27, 2004; revision received April 22, 2004; accepted April 27, 2004.
| Abstract |
|---|
|
|
|---|
Method and Results Three-dimensional palpograms were derived from continuous intravascular ultrasound pullbacks. Patients (n=55) were classified by clinical presentation as having stable angina, unstable angina, or AMI. In every patient, 1 coronary artery was scanned (culprit vessel in stable and unstable angina, nonculprit vessel in AMI), and the number of deformable plaques assessed. Stable angina patients had significantly fewer deformable plaques per vessel (0.6±0.6) than did unstable angina patients (P=0.0019) (1.6±0.7) or AMI patients (P<0.0001) (2.0±0.7). Levels of C-reactive protein were positively correlated with the number of mechanically deformable plaques (R2=0.65, P<0.0001).
Conclusions Three-dimensional intravascular palpography detects strain patterns in human coronary arteries that represent the level of deformation in plaques. The number of highly deformable plaques is correlated with both clinical presentation and levels of C-reactive protein. Further studies will assess the potential role of the technique to identify patients at risk of future clinical events
Key Words: atherosclerosis elasticity plaque ultrasonics catheters
| Introduction |
|---|
|
|
|---|
Plaque rupture is related to weakening of the cap of an atheromatous plaque.2,3 This process may be triggered by an accumulation of inflammatory cells such as macrophages, which produce metalloproteinases.4 Rupture of caps is particularly prone to occur in regions with increased mechanical stress.5 This stress is caused by the pulsatile intravascular blood pressure, which strains the vessel wall.6
Intravascular palpography can measure strain using cross-correlation analysis of radiofrequency ultrasound signals recorded at different intravascular pressures.7 The underlying principle is that the strain of the tissue is a function of its mechanical properties. The local strain of the tissue is displayed color coded (palpogram) on the luminal boundaries of the intravascular ultrasound (IVUS) echogram.8,9
In palpography, a typical strain pattern has been described that has a high sensitivity and specificity (89%) for the detection of thin-cap fibroatheroma in vitro in postmortem coronary arteries.10
We designed the present study to evaluate the incidence of this typical strain pattern in patients undergoing percutaneous coronary intervention (PCI) for stable angina, unstable angina, or acute myocardial infarction (AMI).
| Methods |
|---|
|
|
|---|
The cross-sectional data can be reconstructed as a 3D structure representing either the lumen vessel-wall boundary or as a color-coded map representing the angles versus longitudinal position. Furthermore, a longitudinal crosscut can be made having the echo information with the strain information on the lumen vessel-wall boundary (Figure 1).
|
When a pullback is performed, each palpogram represents the strain information for a certain cross section over the full cardiac cycle. The longitudinal resolution of the 3D acquisitions depends on heart rate and pullback speed. With a heart rate of 60 bpm and a pullback speed of 1.0 mm/s, the longitudinal resolution is 1.0 mm. Movement of the catheter in the artery during acquisition introduces out-of-plane motion. For palpography, this motion is the main source of signal decorrelation and thus a source of error in strain estimation.12 Ideally, the position of the transducer should be as stable as possible, with motion only in the direction of the beam during acquisitions.
In coronary arteries, the natural motion of the catheter, related to blood flow pattern during systole and diastole and to the contraction of the heart, is predictable. During systole, blood flow is low, the heart is contracting, and the catheter moves toward the ostium. In the diastolic phase, blood flow is increasing, the heart is relaxing, and the catheter moves distally away from the ostium.13 For intravascular palpography, data are acquired in the diastolic phase of the heart cycle. In this phase, catheter motion related to the motorized pullback opposes the natural motion of the catheter, related to the cardiac cycle. During the recordings, data were continuously acquired at a pullback speed of 1.0 mm/s using a mechanical pullback device (Trak Back II, Volcano Therapeutics) with simultaneous recording of the ECG and the aortic pressure. The data set is subdivided into heart cycles by use of the R wave of the ECG signal.
Analysis included the complete length of the study vessel, starting with the IVUS pullback distally (in the left anterior descending coronary artery [LAD] at segment 7, American Heart Association classification, and in the right coronary artery [RCA] at segment 3) and ending at the ostium.
Definition of the High-Strain Spot
A region was defined as a high-strain spot when it had high strain (>1.2% at 4 mm Hg pressure difference) that spanned an arc of at least 12° at the surface of a plaque (identified on the IVUS recording) adjacent to low-strain regions (<0.5% at 4 mm Hg pressure difference). The highest value of strain was taken as the strain level of the spot.
Study Population
This cross-sectional study included 55 patients. Seventeen patients had stable angina and underwent elective coronary angioplasty. Nineteen patients had unstable angina, defined as symptomatic transient ST-segment depression with normal biochemical markers of myocardial damage. In stable and unstable patients, palpography was performed in the treated vessel before intervention. Nineteen patients presented with acute ST-segment elevation MI and underwent primary angioplasty <12 hours after onset of symptoms. Palpography was performed in a nonculprit vessel.
No patient was taking antiinflammatory drugs other than aspirin. Our institutional review board approved the protocol, and all patients gave written informed consent.
Lipid and hsCRP Measurements
Venous blood samples were obtained before catheterization. Lipid levels (total cholesterol, LDL) and high-sensitivity C-reactive protein (hsCRP) were determined routinely with standard methods.14
Statistical Analysis
For statistical analysis, SAS version 8.02 (SAS Institute) was used. Data are expressed as mean±SD. Variables were tested for normal distribution with the Shapiro-Wilk test. Values of P<0.05 were considered statistically significant. Continuous variables are also presented as median values with the corresponding 25th and 75th percentiles. To test for independence between categorical groups, Fishers exact test was used. Univariate ANOVA was used to compare continuous data among groups.
| Results |
|---|
|
|
|---|
Palpography in 55 vessels (28 LAD, 27 RCA) identified 97 typical high-strain patterns (spots). In 8 vessels, no high-strain spot was detected; in 21 vessels, 1 spot; in 29 vessels, 2 spots; and in 6 vessels, 3 spots.
Patients with stable angina had 0.6±0.6 highly deformable plaques, with the typical high-strain pattern of a suspected vulnerable plaque. Significantly more highly deformable plaques (1.6±0.7) were found in unstable angina patients (P=0.0019) and in AMI (P<0.0001) patients (2.0±0.7) compared with stable angina patients (Figure 2). There was no significant difference between unstable and AMI patients with regard to the number of highly deformable lesions (P=0.27). Gender had no influence on the number of highly deformable lesions (P=0.90).
|
There was no significant difference (P=0.54) in the overall number of high-strain spots detected in the LAD (n=1.6±0.9) and the RCA (1.3±0.9). The mean length of vessel studied did not differ significantly (P=0.496, ANOVA) among groups: stable angina, 52±14 mm; unstable angina, 51±13 mm; and AMI, 47±14 mm.
hsCRP levels differed significantly among groups (P<0.0001). They were significantly higher in patients with unstable angina (1.2±0.8 µg/mL; P=0.02) or AMI (1.8±0.5 µg/mL; P<0.0001) compared with patients with stable angina (0.6±0.4 µg/mL). hsCRP levels also differed significantly between the unstable angina group and the AMI group (P=0.03). The number of high-strain spots per artery was positively correlated with the hsCRP level (R2=0.65, P<0.0001). For zero high-strain spots, the hsCRP level was 0.3±0.2 µg/mL; for one, 0.8±0.5 µg/mL; for two, 1.7±0.5 µg/mL; and for three, 2.2±0.3 µg/mL. With multivariate analysis, the interaction between clinical presentation, number of deformable plaques, and hsCRP was tested. The clinical presentation did not have a significant effect on the relationship between number of high-strain spots and hsCRP levels (P=0.06). Separate analysis showed, in the stable angina patients, a Pearson correlation of 0.69 with a value of P<0.002; in the unstable angina group, of 0.83 with a value of P<0.0001; and in the AMI group, of 0.50 with a value of P<0.031.
There was no relation between individual risk factors such as hypercholesterolemia (P=0.82), smoking (P=0.73), diabetes (P=0.31), and hypertension (P=0.42) and the number of high-strain spots. The level of LDL among groups did not differ significantly (P=0.26). In the stable angina group, 70.6% were on statins; in the unstable angina group, 68.4%; and in the AMI group, 52.6%. A univariate analysis showed no significant influence of statin use on the number of high-strain spots (P=0.153).
| Discussion |
|---|
|
|
|---|
Intravascular palpography, by its capacity to evaluate the mechanical properties of the plaque, can detect thin-cap fibroatheromas. Validation studies in vitro and in vivo have shown that palpography can identify such plaques with high sensitivity and specificity.10,15 Until now, this method was applied only to the analysis of single cross sections. Because atherosclerosis is a 3D process, the extension of palpography from a 2D to a 3D technique was a necessary prerequisite to its introduction as a potential clinical modality. This technique now permits us to assess the number of suspected vulnerable plaques in the entire coronary artery.
Incidence of High-Strain Patterns: Relation to Clinical Presentation
We found that the incidence of high-strain patterns was strongly related to the clinical presentation. Patients with acute coronary syndromes (unstable angina, AMI) had significantly more high-strain patterns than did patients with stable angina. In the unstable group, there was no significant difference in the number of high-strain patterns in the nonculprit vessel of AMI patients compared with the culprit vessel in unstable angina patients; this supports the hypothesis that inflammation in acute coronary syndromes is a multifocal process.16 The number of high-strains spots we describe is consistent with the number of thin-cap fibroatheromas observed in autopsy studies17,18 and with the number of yellow plaques observed in angioscopic studies.1921
Incidence of High-Strain Patterns: Relation to hsCRP Levels
Inflammation plays an important role in destabilizing plaques. A clear connection between inflammation and cap stability has been described.22 There is increasing evidence that hsCRP not only is a reactive marker but also has proatherogenic characteristics by its pro-oxidative effect.23 hsCRP has a positive predictive value for cardiac events in patients presenting with unstable angina.24,25 We found a positive correlation between the number of high-strain patterns and levels of hsCRP. Our study was not powered to validate a relationship between hsCRP and the number of suspected vulnerable plaques. Furthermore, the high hsCRP level in the AMI group may partly reflect an increase in hsCRP because of myocyte necrosis. However, this reactive increase starts approximately 16 hours after the onset of MI,26 whereas blood samples for hsCRP levels in the present study were obtained <12 hours after the onset of symptoms.27
Future prospective studies should address the value of intravascular palpography in the detection of rupture-prone thin-cap fibroatheromas, in the prediction of clinical events, and as a tool to follow the natural progression and the effect of pharmacological or other interventions.28
Limitation of the Study
We assessed only 1 coronary artery per patient. Risk stratification ideally requires evaluation of the total vulnerable plaque burden. Because of the invasive character of intravascular palpography, this assessment can be justified only if the predictive power of the technique is high enough. Nevertheless, assessment of all coronary arteries in 1 patient is feasible and safe with IVUS, a widely available technique.29 The left circumflex artery was not investigated in this study because of the increased motion of this vessel. A motion compensation method is being developed for future studies.
Conclusions
Three-dimensional intravascular palpography can detect high-strain spots, consistent with plaque vulnerability, in vivo in human coronary arteries. The incidence of such possible vulnerable plaques is correlated with both clinical presentation and markers of inflammation. Additional validation is needed to assess the predictive value of the technique to identify vulnerable patients.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. Ambrose In Search of the "vulnerable plaque": can it be localized and will focal regional therapy ever be an option for cardiac prevention? J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1539 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Honda and P. J. Fitzgerald Frontiers in Intravascular Imaging Technologies Circulation, April 15, 2008; 117(15): 2024 - 2037. [Full Text] [PDF] |
||||
![]() |
P. W. Serruys, H. M. Garcia-Garcia, and E. Regar From Postmortem Characterization to the In Vivo Detection of Thin-Capped Fibroatheromas: The Missing Link Toward Percutaneous Treatment: What If Diogenes Would Have Found What He Was Looking For? J. Am. Coll. Cardiol., September 4, 2007; 50(10): 950 - 952. [Full Text] [PDF] |
||||
![]() |
S. Waxman, F. Ishibashi, and J. E. Muller Detection and Treatment of Vulnerable Plaques and Vulnerable Patients: Novel Approaches to Prevention of Coronary Events Circulation, November 28, 2006; 114(22): 2390 - 2411. [Full Text] [PDF] |
||||
![]() |
R. De Caterina and M. Zimarino Coronary artery remodelling in atherosclerosis: unfortunately unpredictable Eur. Heart J., August 1, 2006; 27(15): 1761 - 1763. [Full Text] [PDF] |
||||
![]() |
P. W. Serruys Fourth Annual American College of Cardiology International Lecture: A Journey in the Interventional Field J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1754 - 1768. [Full Text] [PDF] |
||||
![]() |
J. A. Schaar, A. F.W. van der Steen, F. Mastik, R. A. Baldewsing, and P. W. Serruys Intravascular palpography for vulnerable plaque assessment. J. Am. Coll. Cardiol., April 18, 2006; 47(8 Suppl): C86 - C91. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A.G. Van Mieghem, E. P. McFadden, P. J. de Feyter, N. Bruining, J. A. Schaar, N. R. Mollet, F. Cademartiri, D. Goedhart, S. de Winter, G. R. Granillo, et al. Noninvasive Detection of Subclinical Coronary Atherosclerosis Coupled With Assessment of Changes in Plaque Characteristics Using Novel Invasive Imaging Modalities: The Integrated Biomarker and Imaging Study (IBIS) J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1134 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, E. P. Mc Fadden, M. Valgimigli, J. Aoki, P. de Feyter, and P. W. Serruys In Vivo Intravascular Ultrasound-Derived Thin-Cap Fibroatheroma Detection Using Ultrasound Radiofrequency Data Analysis J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2038 - 2042. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |